Long-term cardio-vascular risk assessment in chronic kidney disease and kidney transplanted patients following SARS-COV-2 disease: protocol for multi-center observational match controlled trial.

Laura TapoiMugurel ApetriiGianina DodiIonut NistorLuminita VoroneanuLucian SiriteanuMihai OnofriescuMehmet KanbayAdrian Covic

Published in: BMC nephrology (2022)

Patient enrolment in the trial started in January 2021 and is expected to finish at the end of 2022. The study can be found on ClinicalTrials.gov database with NCT05125913 identifier. Registered on 18 November 2021 - Retrospectively registered.

Keyphrases

sars cov
risk assessment
end stage renal disease
study protocol
ejection fraction
randomized controlled trial
clinical trial
peritoneal dialysis
prognostic factors
case report
health insurance
heavy metals
human health
patient reported outcomes
cross sectional
adverse drug
coronavirus disease
climate change